CLINICAL_TRIALS trial_result · 2024-10-09

Clinical Trial Update: A Study to Evaluate the Durability of Response of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata [Phase 2]

Phase 2 study evaluating the durability of response to CTP-543 in adults with moderate to severe Alopecia Areata; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Concert Pharmaceuticals | Conditions: Alopecia Areata | Phase 2 | Status: COMPLETED | Results posted: 2024-10-09